Clinical Trial Update: A Safety and Efficacy Study of 2 Dosing Regimens of Recombinant Human Nerve Growth Factor (rhNGF) Eye Drop Solution Compared With Vehicle in Patients With Dry Eye Disease. [Phase 2]

View source ↗

Summary

Phase 2 study evaluating two dosing regimens of recombinant human nerve growth factor eye drops versus vehicle in dry eye disease, with results posted after com…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dry Eye Disease

Drugs mentioned

• rhNGF eye drop solution (recombinant human nerve growth factor)

Snippet

Sponsor: Dompé Farmaceutici S.p.A | Conditions: Dry Eye Disease | Phase 2 | Status: COMPLETED | Results posted: 2026-02-13